Recommended Topic Related To:

Mumps Skin Test Antigen

"The U.S. Food and Drug Administration announced today that injectable drugs used in total parenteral nutrition (TPN) in critical shortage will be imported into the United States and available to patients this week.

TPN is an intravenous"...

Mumps Skin Test Antigen

MSTA®
Mumps Skin Test Antigen USP

NOT FOR IMMUNIZATION, DIAGNOSIS, OR TREATMENT
NOT FOR DIAGNOSIS OF IMMUNITY TO MUMPS

DRUG DESCRIPTION

MSTA®, Mumps Skin Test Antigen, is a sterile suspension of killed mumps virus for intradermal use. It is prepared from the extraembryonic fluid of the virus-infected chicken embryo and is concentrated and purified by differential centrifugation. The virus is killed with formaldehyde solution, 1:1000, and is then diluted with isotonic sodium chloride solution. The resultant product contains approximately 0.012 molar glycine and less than 1:8,000 formaldehyde solution. Thimerosal (mercury derivative) 1:10,000 is added as a preservative. The skin test antigen is formulated to contain at least 40 complement fixing units (CFU) per mL, at the time of release, as determined by the Complement-Fixation Test. This product, after shaking, is slightly opalescent in color.

Last reviewed on RxList: 12/19/2008
This monograph has been modified to include the generic and brand name in many instances.

A A A

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.